These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32048335)

  • 1. Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption.
    Becker P; Lecerf P; Claereboudt J; Devleesschauwer B; Packeu A; Hendrickx M
    Mycoses; 2020 May; 63(5):500-508. PubMed ID: 32048335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.
    Goemaere B; Lagrou K; Spriet I; Hendrickx M; Vandael E; Becker P; Catry B
    Mycoses; 2019 Jun; 62(6):542-550. PubMed ID: 30887582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug utilization study of systemic antifungal agents in a Brazilian tertiary care hospital.
    de Souza MC; Dos Santos AG; Reis AM
    Int J Clin Pharm; 2016 Dec; 38(6):1398-1406. PubMed ID: 27714625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight.
    Adriaenssens N; Coenen S; Versporten A; Goossens H
    Int J Antimicrob Agents; 2013 Nov; 42(5):466-70. PubMed ID: 23993932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of Antifungal Use Based on Sales Data in Japan from 2006 to 2015.
    Kawabe A; Muraki Y; Inose R; Kusama Y; Goto R; Ebisui A; Ishii S; Ishikane M; Ohge H; Ohmagari N
    Biol Pharm Bull; 2020; 43(8):1248-1252. PubMed ID: 32741945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice.
    Galatti L; Mazzaglia G; Greco A; Sessa E; Cricelli C; Schito GC; Nicoletti G; Spina E; Caputi AP
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):422-8. PubMed ID: 17323404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal stewardship in a tertiary-care institution: a bedside intervention.
    Valerio M; Muñoz P; Rodríguez CG; Caliz B; Padilla B; Fernández-Cruz A; Sánchez-Somolinos M; Gijón P; Peral J; Gayoso J; Frias I; Salcedo M; Sanjurjo M; Bouza E;
    Clin Microbiol Infect; 2015 May; 21(5):492.e1-9. PubMed ID: 25748494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-year study of fungal infections in Rio Grande do Sul, Southern Brazil.
    Fay VDS; Gregianini TS; Veiga ABGD; Gonçalves SMB; Rodrigues DM; Bonamigo RR
    Rev Iberoam Micol; 2019; 36(2):55-60. PubMed ID: 31014946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M; Bryson HM; Goa KL
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship.
    Valerio M; Vena A; Rodríguez-González CG; de Vega EC; Mateos M; Sanjurjo M; Bouza E; Muñoz P;
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1993-2000. PubMed ID: 30078143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.
    Fondevilla E; Grau S; Mojal S; Palomar M; Matas L; Gudiol F;
    Expert Rev Anti Infect Ther; 2016; 14(1):137-44. PubMed ID: 26466197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic antifungal therapy: new options, new challenges.
    Wong-Beringer A; Kriengkauykiat J
    Pharmacotherapy; 2003 Nov; 23(11):1441-62. PubMed ID: 14620391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study to evaluate the price control of antifungal medicines and its practical applicability.
    Sil A; Das NK; Ghosh P; Datta PK; Islam CN; Tripathi SK
    Indian J Pharmacol; 2012; 44(6):704-9. PubMed ID: 23248398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
    Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
    Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.
    Nivoix Y; Launoy A; Lutun P; Moulin JC; Phai Pang KA; Fornecker LM; Wolf M; Levêque D; Letscher-Bru V; Beretz L; Ubeaud-Sequier G; Herbrecht R
    J Antimicrob Chemother; 2012 Oct; 67(10):2506-13. PubMed ID: 22778159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of high-priced systemic antifungal prescriptions.
    Poulat C; Nivoix Y; Launoy A; Lutun P; Bachellier P; Rohr S; Woehl ML; Levêque D; Bru V; Herbrecht R; Gourieux B
    Med Mal Infect; 2017 Oct; 47(6):382-388. PubMed ID: 28412043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of topical antifungal agents].
    Dupont B
    Therapie; 2006; 61(3):251-4. PubMed ID: 16989127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
    Schonfeld W; Wang Cheng J; Tong KB; Seifeldin R
    Clin Ther; 2008 May; 30(5):964-73. PubMed ID: 18555943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.